Thermo Fisher Scientific Total Assets 2010-2022 | TMO

Thermo Fisher Scientific total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Thermo Fisher Scientific total assets for the quarter ending September 30, 2022 were $90.536B, a 23.01% increase year-over-year.
  • Thermo Fisher Scientific total assets for 2021 were $95.123B, a 37.76% increase from 2020.
  • Thermo Fisher Scientific total assets for 2020 were $69.052B, a 18.28% increase from 2019.
  • Thermo Fisher Scientific total assets for 2019 were $58.381B, a 3.82% increase from 2018.
Thermo Fisher Scientific Annual Total Assets
(Millions of US $)
2021 $95,123
2020 $69,052
2019 $58,381
2018 $56,232
2017 $56,669
2016 $45,908
2015 $40,834
2014 $42,852
2013 $31,863
2012 $27,445
2011 $26,834
2010 $21,349
2009 $21,625
Thermo Fisher Scientific Quarterly Total Assets
(Millions of US $)
2022-09-30 $90,536
2022-06-30 $90,579
2022-03-31 $92,747
2021-12-31 $95,123
2021-09-30 $73,600
2021-06-30 $67,698
2021-03-31 $65,931
2020-12-31 $69,052
2020-09-30 $64,061
2020-06-30 $61,593
2020-03-31 $58,688
2019-12-31 $58,381
2019-09-30 $56,729
2019-06-30 $57,970
2019-03-31 $55,596
2018-12-31 $56,232
2018-09-30 $55,078
2018-06-30 $55,403
2018-03-31 $56,580
2017-12-31 $56,669
2017-09-30 $55,985
2017-06-30 $46,514
2017-03-31 $46,214
2016-12-31 $45,908
2016-09-30 $48,011
2016-06-30 $42,253
2016-03-31 $42,953
2015-12-31 $40,834
2015-09-30 $41,147
2015-06-30 $41,774
2015-03-31 $41,857
2014-12-31 $42,852
2014-09-30 $42,691
2014-06-30 $44,313
2014-03-31 $46,134
2013-12-31 $31,863
2013-09-30 $28,273
2013-06-30 $27,630
2013-03-31 $27,411
2012-12-31 $27,445
2012-09-30 $27,578
2012-06-30 $26,361
2012-03-31 $26,823
2011-12-31 $26,834
2011-09-30 $26,992
2011-06-30 $24,074
2011-03-31 $23,431
2010-12-31 $21,349
2010-09-30 $21,537
2010-06-30 $21,281
2010-03-31 $21,625
2009-12-31 $21,625
2009-09-30 $21,419
2009-06-30 $21,156
2009-03-31 $21,033
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $220.806B $39.211B
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.
Stock Name Country Market Cap PE Ratio
Edwards Lifesciences (EW) United States $47.328B 32.57
Alcon (ALC) Switzerland $34.365B 29.59
STERIS (STE) Ireland $19.157B 23.84
Teleflex (TFX) United States $11.379B 18.46
Fresenius Medical Care AG KGaA (FMS) Germany $9.600B 9.64
Penumbra (PEN) United States $8.008B 1916.82
Globus Medical (GMED) United States $7.483B 38.05
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00